GrantRover ↗

← Tüm fırsatlar

Defense Health Agency Contracting Activity - DHACA · ABD

DoW Rare Cancers Resource and Community Development Award

Açık

Defense Health Agency Contracting Activity - DHACA tarafından 5 hibe bekleniyor; toplam bütçe $5,6 milyon. Başvurular 18 Kasım 2026 tarihinde kapanıyor. Uygun başvuru sahibi türleri (kaynakta): Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility".

Son başvuru
18 Kasım 2026 (3 gün kaldı)
Hibe tutarı
Hibe başına ≈ $1,12 milyon (tahmin: toplam ÷ 5 hibe)
Toplam bütçe
$5,6 milyon
Destek oranı
Zorunlu eş finansman belirtilmemiş; destek oranı belirtilmemiş
Toplam bütçe
$5,6 milyon
Beklenen hibe sayısı
5
Eş finansman
Gerekli değil
Olası başvuru sahipleri
Şirketler, KOBİ’ler / girişimler, Kâr amacı gütmeyenler, Üniversiteler ve araştırma, Kamu kurumları, Bireyler Kaynak kategorilerinden veya program kurallarından; uygunluğa çağrı karar verir.
Fon sağlayıcı
Defense Health Agency Contracting Activity - DHACA
Referans
HT942526RCRPRCDA
Destek listesi (ABD)
12.420 Military Medical Research and Development
Son kontrol
13 Kasım 2026

Resmi çağrıyı aç ↗ Son tarihi takvime ekle

Resmi açıklamalar fon sağlayıcının dilindedir (çoğunlukla İngilizce); bu sayfadaki özet ve temel bilgiler Türkçedir.

Çağrı hakkında

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical datasets that will advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Research supporting this funding opportunity should fill one of the following major gaps:

• Lack of research and clinical resources, including patient tissues, cell and tumor models.

• Lack of communication and dissemination strategies within scientific and patient communities for sharing rare cancers research and clinical findings.

• Lack of infrastructure for sharing data and other resources.

• Lack of therapeutics and mechanistic research to inform treatment development.

Distinctive Features:

• Documentation of plans for engagement and partnerships with Patient Advocates throughout the life cycle of the research study from development of the research question through execution of the study.

Tam metni oku

• Community building and enhancement are key components.

• A description of the dissemination and sustainability of the platform for scientific and/or clinical and patient community is required.

• Preliminary data are not required but may be included to address feasibility.

Kimler başvurabilir

Başvuru sahibi kategorileri yalnızca bir başlangıç noktasıdır. Uygunluğa resmi çağrı karar verir.

Konular

Science and Technology and other Research and Development

Nasıl başvurulur

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. Register with Grants.gov and set up a Workspace for this opportunity, with the right roles for your organisation.
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

İletişim

JoAnn Martin · help@eBRAP.org · 301-619-2594

Resmi kaynaklar

Resmi çağrı sayfası

Bu sayfadaki bilgiler resmi kaynaktan alınmıştır ve en son 13 Kasım 2026 tarihinde kontrol edilmiştir. Sonraki değişiklikler dahil, fon sağlayıcının kendi belgeleri her zaman önceliklidir.

Defense Health Agency Contracting Activity - DHACA: diğer çağrılar

Defense Health Agency Contracting Activity - DHACA ABD

DoW Joint Warfighter Medical, Military Medical Research and Development Award

HT942526JWMRPMMRDA

Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fu…

Defense Health Agency Contracting Activity - DHACA ABD

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

HT942526BCRPBTA122

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make…

Defense Health Agency Contracting Activity - DHACA ABD

DoW Breast Cancer, Clinical Research Extension Award

HT942526BCRPCREA2

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up…

Defense Health Agency Contracting Activity - DHACA ABD

DOW Combat Readiness – Medical Research Program Translational Research Award

HT942526CRRPTRA

Summary: The fiscal year 2026 (FY26) Combat Readiness – Medical Research Program (CRRP) Translational Research Award (TRA) supports hypothesis-driven innovative, high-imp…

Defense Health Agency Contracting Activity - DHACA ABD

DoW Orthopaedic, Applied Research Award

HT942526ORPARA

Summary: The Orthopaedic Research Program (ORP) Applied Research Award (ARA) seeks applied research applications focused on advancing optimal treatment and restoration of…